Clinuvel Pharmaceuticals Ltd. CUVL · News

website

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commerciali...

Price5.18

Market Cap261.22 M

Float46.62 M

CountryAU

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

FEATURED

A decade of profitability provides foundation for CLINUVEL’s U.S. expansion

MELBOURNE, Australia and NEW YORK, Aug. 27, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD ((ASX: CUV, NASDAQ:CUVL) today announced its tenth consecutive annual profit and further rise in free cash in the

Summary

Aug 27, 2026, 1:42 AM ·Globe Newswire

RECENT

CLINUVEL implements strategic reorganisation to refocus on U.S. markets

MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD ((ASX: CUV, NASDAQ:CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1

Jul 23, 2026, 12:10 AM ·Globe Newswire

CLINUVEL’s ADS to commence trading on Nasdaq

MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market

Jul 20, 2026, 1:37 AM ·Globe Newswire